Quantcast

Industry news that matters to you.  Learn more

RadMD Presents at BIO International Convention 2011

Reading time: 2 minutes

Dr. Kohkan Shamsi, Principal at RadMD, led one of the key Biomarker sessions at this year’s annual BIO International Convention in Washington DC. The event features keynotes and sessions from key policymakers, scientists, CEOs, and celebrities. The Convention also features hundreds of sessions covering biotech trends, policy issues and technological innovations, as well as the world’s largest biotechnology exhibition.

In addition to moderating the session, Dr. Shamsi presented along with Dwayne Reives, MD Division of Medical Imaging and Hematology FDA, Larry Schwartz, MD Professor and Chairman of Radiology Columbia University and Medical Center, and Erik Pulkstenis, PhD Director Biostatistics Human Genome Sciences, on the Use of Imaging in Clinical Development: Risk Management Strategies for Site and Independent Image Evaluations.

The presenters expanded on the complexities of using imaging in clinical trials, which require multilevel risk management strategies to ensure regulatory compliant data. The various risk management strategies include prospectively defining image acquisition methodology, image evaluation paradigms, and reader selection and training. Based on these expert presentations, the participants were able to gain insight into the pros and cons of site vs. central read of imaging data in trials, understand the current regulatory environment and learn how to implement risk management strategies when using imaging in clinical trials.

“We are very pleased to have been able to assemble such an esteemed panel to discuss these critical issues of medical imaging in clinical trials,” said Dr. Shamsi. “The use of imaging in clinical trials continues to evolve, and we at RadMD remain committed in our efforts to inform and educate around this important topic.”

Source: Marketwire